 | • レポートコード：MRC2-11QY12530 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肝硬変のグローバル市場について調査・分析したレポートです。種類別（アルコール性肝硬変、萎縮性肝硬変、胆汁性肝硬変、心臓性肝硬変、クリプトジェニック肝硬変）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肝硬変の競争状況、市場シェア ・世界の肝硬変市場：種類別市場規模 2015年-2020年（アルコール性肝硬変、萎縮性肝硬変、胆汁性肝硬変、心臓性肝硬変、クリプトジェニック肝硬変） ・世界の肝硬変市場：種類別市場規模予測 2021年-2026年（アルコール性肝硬変、萎縮性肝硬変、胆汁性肝硬変、心臓性肝硬変、クリプトジェニック肝硬変） ・世界の肝硬変市場：用途別市場規模 2015年-2020年（病院、専門クリニック） ・世界の肝硬変市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック） ・北米の肝硬変市場分析：米国、カナダ ・ヨーロッパの肝硬変市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肝硬変市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肝硬変市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肝硬変市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：F Hoffman La-Roche、GlaxoSmithKline、Gilead Sciences、Johnson & Johnson、Merck、Bristol-Myers Squibb、Conatus Pharmaceuticals、Gwo Xi Stem Cell Applied Technology、Instituto Grifols、Intercept Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse.
Alcohol has been identified as the strongest risk factor for liver cirrhosis.
Market Analysis and Insights: Global Liver Cirrhosis Market
The global Liver Cirrhosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Liver Cirrhosis Scope and Market Size
Liver Cirrhosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liver Cirrhosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
F Hoffman La-Roche
GlaxoSmithKline
Gilead Sciences
Johnson & Johnson
Merck
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
Intercept Pharmaceuticals
Market segment by Type, the product can be split into
Alcoholic Cirrhosis
Atrophic Cirrhosis
Biliary Cirrhosis
Cardiac Cirrhosis
Cryptogenic Cirrhosis
Market segment by Application, split into
Hospitals
Specialty Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liver Cirrhosis Revenue
1.4 Market by Type
1.4.1 Global Liver Cirrhosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Alcoholic Cirrhosis
1.4.3 Atrophic Cirrhosis
1.4.4 Biliary Cirrhosis
1.4.5 Cardiac Cirrhosis
1.4.6 Cryptogenic Cirrhosis
1.5 Market by Application
1.5.1 Global Liver Cirrhosis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Liver Cirrhosis Market Perspective (2015-2026)
2.2 Global Liver Cirrhosis Growth Trends by Regions
2.2.1 Liver Cirrhosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liver Cirrhosis Historic Market Share by Regions (2015-2020)
2.2.3 Liver Cirrhosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Liver Cirrhosis Market Growth Strategy
2.3.6 Primary Interviews with Key Liver Cirrhosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Liver Cirrhosis Players by Market Size
3.1.1 Global Top Liver Cirrhosis Players by Revenue (2015-2020)
3.1.2 Global Liver Cirrhosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Liver Cirrhosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liver Cirrhosis Market Concentration Ratio
3.2.1 Global Liver Cirrhosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liver Cirrhosis Revenue in 2019
3.3 Liver Cirrhosis Key Players Head office and Area Served
3.4 Key Players Liver Cirrhosis Product Solution and Service
3.5 Date of Enter into Liver Cirrhosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Liver Cirrhosis Historic Market Size by Type (2015-2020)
4.2 Global Liver Cirrhosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Liver Cirrhosis Market Size by Application (2015-2020)
5.2 Global Liver Cirrhosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Liver Cirrhosis Market Size (2015-2020)
6.2 Liver Cirrhosis Key Players in North America (2019-2020)
6.3 North America Liver Cirrhosis Market Size by Type (2015-2020)
6.4 North America Liver Cirrhosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Liver Cirrhosis Market Size (2015-2020)
7.2 Liver Cirrhosis Key Players in Europe (2019-2020)
7.3 Europe Liver Cirrhosis Market Size by Type (2015-2020)
7.4 Europe Liver Cirrhosis Market Size by Application (2015-2020)
8 China
8.1 China Liver Cirrhosis Market Size (2015-2020)
8.2 Liver Cirrhosis Key Players in China (2019-2020)
8.3 China Liver Cirrhosis Market Size by Type (2015-2020)
8.4 China Liver Cirrhosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Liver Cirrhosis Market Size (2015-2020)
9.2 Liver Cirrhosis Key Players in Japan (2019-2020)
9.3 Japan Liver Cirrhosis Market Size by Type (2015-2020)
9.4 Japan Liver Cirrhosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Liver Cirrhosis Market Size (2015-2020)
10.2 Liver Cirrhosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liver Cirrhosis Market Size by Type (2015-2020)
10.4 Southeast Asia Liver Cirrhosis Market Size by Application (2015-2020)
11 India
11.1 India Liver Cirrhosis Market Size (2015-2020)
11.2 Liver Cirrhosis Key Players in India (2019-2020)
11.3 India Liver Cirrhosis Market Size by Type (2015-2020)
11.4 India Liver Cirrhosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Liver Cirrhosis Market Size (2015-2020)
12.2 Liver Cirrhosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Liver Cirrhosis Market Size by Type (2015-2020)
12.4 Central & South America Liver Cirrhosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 F Hoffman La-Roche
13.1.1 F Hoffman La-Roche Company Details
13.1.2 F Hoffman La-Roche Business Overview
13.1.3 F Hoffman La-Roche Liver Cirrhosis Introduction
13.1.4 F Hoffman La-Roche Revenue in Liver Cirrhosis Business (2015-2020))
13.1.5 F Hoffman La-Roche Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Liver Cirrhosis Introduction
13.2.4 GlaxoSmithKline Revenue in Liver Cirrhosis Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 Gilead Sciences
13.3.1 Gilead Sciences Company Details
13.3.2 Gilead Sciences Business Overview
13.3.3 Gilead Sciences Liver Cirrhosis Introduction
13.3.4 Gilead Sciences Revenue in Liver Cirrhosis Business (2015-2020)
13.3.5 Gilead Sciences Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Liver Cirrhosis Introduction
13.4.4 Johnson & Johnson Revenue in Liver Cirrhosis Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Merck
13.5.1 Merck Company Details
13.5.2 Merck Business Overview
13.5.3 Merck Liver Cirrhosis Introduction
13.5.4 Merck Revenue in Liver Cirrhosis Business (2015-2020)
13.5.5 Merck Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Liver Cirrhosis Introduction
13.6.4 Bristol-Myers Squibb Revenue in Liver Cirrhosis Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Conatus Pharmaceuticals
13.7.1 Conatus Pharmaceuticals Company Details
13.7.2 Conatus Pharmaceuticals Business Overview
13.7.3 Conatus Pharmaceuticals Liver Cirrhosis Introduction
13.7.4 Conatus Pharmaceuticals Revenue in Liver Cirrhosis Business (2015-2020)
13.7.5 Conatus Pharmaceuticals Recent Development
13.8 Gwo Xi Stem Cell Applied Technology
13.8.1 Gwo Xi Stem Cell Applied Technology Company Details
13.8.2 Gwo Xi Stem Cell Applied Technology Business Overview
13.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Introduction
13.8.4 Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Business (2015-2020)
13.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
13.9 Instituto Grifols
13.9.1 Instituto Grifols Company Details
13.9.2 Instituto Grifols Business Overview
13.9.3 Instituto Grifols Liver Cirrhosis Introduction
13.9.4 Instituto Grifols Revenue in Liver Cirrhosis Business (2015-2020)
13.9.5 Instituto Grifols Recent Development
13.10 Intercept Pharmaceuticals
13.10.1 Intercept Pharmaceuticals Company Details
13.10.2 Intercept Pharmaceuticals Business Overview
13.10.3 Intercept Pharmaceuticals Liver Cirrhosis Introduction
13.10.4 Intercept Pharmaceuticals Revenue in Liver Cirrhosis Business (2015-2020)
13.10.5 Intercept Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Liver Cirrhosis Key Market Segments
Table 2. Key Players Covered: Ranking by Liver Cirrhosis Revenue
Table 3. Ranking of Global Top Liver Cirrhosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liver Cirrhosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Alcoholic Cirrhosis
Table 6. Key Players of Atrophic Cirrhosis
Table 7. Key Players of Biliary Cirrhosis
Table 8. Key Players of Cardiac Cirrhosis
Table 9. Key Players of Cryptogenic Cirrhosis
Table 10. Global Liver Cirrhosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Liver Cirrhosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Liver Cirrhosis Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Liver Cirrhosis Market Share by Regions (2015-2020)
Table 14. Global Liver Cirrhosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Liver Cirrhosis Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Liver Cirrhosis Market Growth Strategy
Table 20. Main Points Interviewed from Key Liver Cirrhosis Players
Table 21. Global Liver Cirrhosis Revenue by Players (2015-2020) (Million US$)
Table 22. Global Liver Cirrhosis Market Share by Players (2015-2020)
Table 23. Global Top Liver Cirrhosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis as of 2019)
Table 24. Global Liver Cirrhosis by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Liver Cirrhosis Product Solution and Service
Table 27. Date of Enter into Liver Cirrhosis Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 30. Global Liver Cirrhosis Market Size Share by Type (2015-2020)
Table 31. Global Liver Cirrhosis Revenue Market Share by Type (2021-2026)
Table 32. Global Liver Cirrhosis Market Size Share by Application (2015-2020)
Table 33. Global Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 34. Global Liver Cirrhosis Market Size Share by Application (2021-2026)
Table 35. North America Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Liver Cirrhosis Market Share (2019-2020)
Table 37. North America Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 38. North America Liver Cirrhosis Market Share by Type (2015-2020)
Table 39. North America Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 40. North America Liver Cirrhosis Market Share by Application (2015-2020)
Table 41. Europe Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Liver Cirrhosis Market Share (2019-2020)
Table 43. Europe Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Liver Cirrhosis Market Share by Type (2015-2020)
Table 45. Europe Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Liver Cirrhosis Market Share by Application (2015-2020)
Table 47. China Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 48. China Key Players Liver Cirrhosis Market Share (2019-2020)
Table 49. China Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 50. China Liver Cirrhosis Market Share by Type (2015-2020)
Table 51. China Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 52. China Liver Cirrhosis Market Share by Application (2015-2020)
Table 53. Japan Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Liver Cirrhosis Market Share (2019-2020)
Table 55. Japan Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Liver Cirrhosis Market Share by Type (2015-2020)
Table 57. Japan Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Liver Cirrhosis Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Liver Cirrhosis Market Share (2019-2020)
Table 61. Southeast Asia Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Liver Cirrhosis Market Share by Type (2015-2020)
Table 63. Southeast Asia Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Liver Cirrhosis Market Share by Application (2015-2020)
Table 65. India Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 66. India Key Players Liver Cirrhosis Market Share (2019-2020)
Table 67. India Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 68. India Liver Cirrhosis Market Share by Type (2015-2020)
Table 69. India Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 70. India Liver Cirrhosis Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Liver Cirrhosis Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Liver Cirrhosis Market Share (2019-2020)
Table 73. Central & South America Liver Cirrhosis Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Liver Cirrhosis Market Share by Type (2015-2020)
Table 75. Central & South America Liver Cirrhosis Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Liver Cirrhosis Market Share by Application (2015-2020)
Table 77. F Hoffman La-Roche Company Details
Table 78. F Hoffman La-Roche Business Overview
Table 79. F Hoffman La-Roche Product
Table 80. F Hoffman La-Roche Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 81. F Hoffman La-Roche Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Product
Table 85. GlaxoSmithKline Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 86. GlaxoSmithKline Recent Development
Table 87. Gilead Sciences Company Details
Table 88. Gilead Sciences Business Overview
Table 89. Gilead Sciences Product
Table 90. Gilead Sciences Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 91. Gilead Sciences Recent Development
Table 92. Johnson & Johnson Company Details
Table 93. Johnson & Johnson Business Overview
Table 94. Johnson & Johnson Product
Table 95. Johnson & Johnson Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 96. Johnson & Johnson Recent Development
Table 97. Merck Company Details
Table 98. Merck Business Overview
Table 99. Merck Product
Table 100. Merck Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 101. Merck Recent Development
Table 102. Bristol-Myers Squibb Company Details
Table 103. Bristol-Myers Squibb Business Overview
Table 104. Bristol-Myers Squibb Product
Table 105. Bristol-Myers Squibb Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 106. Bristol-Myers Squibb Recent Development
Table 107. Conatus Pharmaceuticals Company Details
Table 108. Conatus Pharmaceuticals Business Overview
Table 109. Conatus Pharmaceuticals Product
Table 110. Conatus Pharmaceuticals Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 111. Conatus Pharmaceuticals Recent Development
Table 112. Gwo Xi Stem Cell Applied Technology Business Overview
Table 113. Gwo Xi Stem Cell Applied Technology Product
Table 114. Gwo Xi Stem Cell Applied Technology Company Details
Table 115. Gwo Xi Stem Cell Applied Technology Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 116. Gwo Xi Stem Cell Applied Technology Recent Development
Table 117. Instituto Grifols Company Details
Table 118. Instituto Grifols Business Overview
Table 119. Instituto Grifols Product
Table 120. Instituto Grifols Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 121. Instituto Grifols Recent Development
Table 122. Intercept Pharmaceuticals Company Details
Table 123. Intercept Pharmaceuticals Business Overview
Table 124. Intercept Pharmaceuticals Product
Table 125. Intercept Pharmaceuticals Revenue in Liver Cirrhosis Business (2015-2020) (Million US$)
Table 126. Intercept Pharmaceuticals Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Cirrhosis Market Share by Type: 2020 VS 2026
Figure 2. Alcoholic Cirrhosis Features
Figure 3. Atrophic Cirrhosis Features
Figure 4. Biliary Cirrhosis Features
Figure 5. Cardiac Cirrhosis Features
Figure 6. Cryptogenic Cirrhosis Features
Figure 7. Global Liver Cirrhosis Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Liver Cirrhosis Report Years Considered
Figure 11. Global Liver Cirrhosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Liver Cirrhosis Market Share by Regions: 2020 VS 2026
Figure 13. Global Liver Cirrhosis Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Liver Cirrhosis Market Share by Players in 2019
Figure 16. Global Top Liver Cirrhosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Liver Cirrhosis Revenue in 2019
Figure 18. North America Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Liver Cirrhosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
肝硬変治療薬の世界市場（～2026年） Market Analysis and Insights: Global Liver Cirrhosis Therapeutics Market The global Liver Cirrhosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Liver Cirrhosis Therapeutics Scope and Market Size Liver …- 原発性胆汁性肝硬変薬の世界市場（～2026年） Market Analysis and Insights: Global Primary Biliary Cirrhosis Drug Market The global Primary Biliary Cirrhosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Primary Biliary Cirrhosis Drug Scope and Market Size …
- 非アルコール性脂肪性肝疾患治療の世界市場（～2026年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 肝性脳症（HE）治療薬の世界市場（～2026年） HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood. The availability of patient-focused programs to assist disease management is one of the primary growth drivers for the global hepatic encephalopathy (HE) therapeutic…